TRPH-222 Preclinical Development and Interim Phase I Data: Enhancing Clinical Safety and Overcoming ADC Manufacturing Challenges with SMARTag® Technology. When you register to watch this on-demand webinar, you'll also sign up for our mailing list and agree to receive updates from ADC Review | Journal of Antibody-drug Conjugates and the sponsors of this webinar, Catalent, and Triphase.
By submitting this form, you are consenting to receive marketing emails from: Sunvalley Communication, LLC, 4960 S. Gilbert Road, Suite 1-286, Chandler, AZ 85249, US, http://www.sunvalleycommunication.com You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
